PHARMA TECHNICAL SOLUTIONS LIMITED

Company number 09434213 ·

Active

Net assets, total assets & total liabilities 2017 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£50k -£25k £0 £25k £50k £75k £100k £125k 2017 2018 2019 2020 2020 2021 2022 2023 2024 2025 Total assets 2017: £49,618 Total assets 2018: £112,459 Total assets 2019: £80,116 Total assets 2020: £57,336 Total assets 2020: £57,336 Total assets 2021: £14,903 Total assets 2022: £52,300 Total assets 2023: £54,397 Total assets 2024: £80,319 Total assets 2025: £61,387 Total assets Net assets 2019: £56,085 Net assets 2020: £8,802 Net assets 2020: £8,802 Net assets 2021: £11,849 Net assets 2022: £21,467 Net assets 2023: £30,440 Net assets 2024: £44,971 Net assets 2025: £31,411 Net assets Total liabilities 2017: -£41,970 Total liabilities 2018: -£43,342 Total liabilities 2019: -£24,031 Total liabilities 2020: -£48,534 Total liabilities 2020: -£47,474 Total liabilities 2021: -£2,754 Total liabilities 2022: -£30,833 Total liabilities 2023: -£23,957 Total liabilities 2024: -£35,348 Total liabilities 2025: -£32,061 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 1 1 2 2 3 2024 2025 2024: 3 2025: 3

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2025-03-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-03-31 £61,387 -£32,061 £31,411 3
2024-02-29 £80,319 -£35,348 £44,971 3
2023-02-28 £54,397 -£23,957 £30,440
2022-02-28 £52,300 -£30,833 £21,467
2021-02-28 £14,903 -£2,754 £11,849
2020-02-29 £57,336 -£47,474 £8,802
2020-02-28 £57,336 -£48,534 £8,802 £47,736
2019-02-28 £80,116 -£24,031 £56,085 £59,943
2018-02-28 £112,459 -£43,342 £101,278
2017-02-28 £49,618 -£41,970 £33,290
2016-02-28 £37,631 -£37,133 £30,992

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.